ATE451913T1 - SUBCUTANEOUS IMPLANTS THAT RELEASE AN ACTIVE SUBSTANCE OVER A LONGER PERIOD - Google Patents

SUBCUTANEOUS IMPLANTS THAT RELEASE AN ACTIVE SUBSTANCE OVER A LONGER PERIOD

Info

Publication number
ATE451913T1
ATE451913T1 AT07788137T AT07788137T ATE451913T1 AT E451913 T1 ATE451913 T1 AT E451913T1 AT 07788137 T AT07788137 T AT 07788137T AT 07788137 T AT07788137 T AT 07788137T AT E451913 T1 ATE451913 T1 AT E451913T1
Authority
AT
Austria
Prior art keywords
release
subcutaneous implants
active substance
longer period
substance over
Prior art date
Application number
AT07788137T
Other languages
German (de)
Inventor
Patrice Mauriac
Pierre Marion
Original Assignee
Mediolanum Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Pharmaceuticals Ltd filed Critical Mediolanum Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE451913T1 publication Critical patent/ATE451913T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Abstract

Subcutaneous implants obtained by extrusion containing (1) microparticles 5 containing an active ingredient dispersed in a PLGA matrix, and optionally microparticles (2) consisting of the same active ingredient or (2') of a different active ingredient preferably belonging to the same category as that contained in (1) all said microparticles (1) being dispersed in a matrix of PLGA (3), having a glass transition temperature lower than that of the PLGA contained in (1).
AT07788137T 2006-08-02 2007-08-01 SUBCUTANEOUS IMPLANTS THAT RELEASE AN ACTIVE SUBSTANCE OVER A LONGER PERIOD ATE451913T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001545A ITMI20061545A1 (en) 2006-08-02 2006-08-02 PARTICLES ABLE TO RELEASE THE ACTIVE PRINCIPLE FOR A PROLONGED PERIOD OF TIME
PCT/EP2007/057969 WO2008015238A2 (en) 2006-08-02 2007-08-01 Subcutaneous implants releasing an active principle over an extended period of time

Publications (1)

Publication Number Publication Date
ATE451913T1 true ATE451913T1 (en) 2010-01-15

Family

ID=37846057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07788137T ATE451913T1 (en) 2006-08-02 2007-08-01 SUBCUTANEOUS IMPLANTS THAT RELEASE AN ACTIVE SUBSTANCE OVER A LONGER PERIOD

Country Status (18)

Country Link
US (1) US20100003298A1 (en)
EP (1) EP2054037B1 (en)
JP (1) JP2009545564A (en)
KR (1) KR20090037946A (en)
CN (1) CN101553212A (en)
AT (1) ATE451913T1 (en)
AU (1) AU2007280397A1 (en)
BR (1) BRPI0714515A2 (en)
CA (1) CA2659441A1 (en)
DE (1) DE602007003854D1 (en)
EA (1) EA017292B1 (en)
ES (1) ES2337419T3 (en)
HK (1) HK1129835A1 (en)
IT (1) ITMI20061545A1 (en)
MX (1) MX2009001232A (en)
PL (1) PL2054037T3 (en)
PT (1) PT2054037E (en)
WO (1) WO2008015238A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010010016A (en) * 2008-03-20 2010-09-30 Organon Nv Preparation of a pharmaceutical composition for increasing bone mineral density.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
IT1304152B1 (en) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl COMPOSITIONS INCLUDING A PEPTIDE AND POLYLACTIC-GLYCOLIC ACID FOR THE PREPARATION OF SUBCUTANEOUS IMPLANTS HAVING A PROLONGED
ES2291893T3 (en) * 2003-06-26 2008-03-01 Mediolanum Pharmaceuticals Limited SUBCUTANEOUS IMPLANTS WITH LIMITED INITIAL RELEASE OF THE ACTIVE AND SUBSEQUENT PRINCIPLE LINEARLY VARIABLE LONG RELEASE OF THE SAME.
WO2005084710A2 (en) * 2004-03-02 2005-09-15 Massachusetts Institute Of Technology Nanocell drug delivery system

Also Published As

Publication number Publication date
WO2008015238A3 (en) 2008-03-20
DE602007003854D1 (en) 2010-01-28
JP2009545564A (en) 2009-12-24
EP2054037B1 (en) 2009-12-16
EA017292B1 (en) 2012-11-30
EP2054037A2 (en) 2009-05-06
PT2054037E (en) 2010-03-24
US20100003298A1 (en) 2010-01-07
ITMI20061545A1 (en) 2008-02-03
AU2007280397A1 (en) 2008-02-07
WO2008015238A2 (en) 2008-02-07
HK1129835A1 (en) 2009-12-11
PL2054037T3 (en) 2010-05-31
WO2008015238A8 (en) 2008-06-05
KR20090037946A (en) 2009-04-16
MX2009001232A (en) 2009-04-28
CN101553212A (en) 2009-10-07
ES2337419T3 (en) 2010-04-23
CA2659441A1 (en) 2008-02-07
EA200900247A1 (en) 2009-06-30
BRPI0714515A2 (en) 2013-04-24

Similar Documents

Publication Publication Date Title
PH12020550162A1 (en) Multispecific antigen-binding molecule having blood coagulation factor viii (fviii) cofactor function-substituting activity, and pharmaceutical formulation containing said molecule as active ingredient
EA201290596A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE ETHERS OF FUMAR ACID IN A DECOMPATED MATRIX
BRPI0511441A (en) compositions containing a hollow glucan particle or cell wall particle encapsulating a terpene component, methods of manufacture and use thereof
DE602007007338D1 (en) SUBCUTANEOUS IMPLANTS THAT RELEASE AN ACTIVE AGENT FOR A LONGER PERIOD
TW200630128A (en) Active ingredient-containing silicone elastomers
MX362908B (en) Drug-containing implants and methods of use thereof.
JP2008518699A5 (en)
MX336349B (en) Insecticide-comprising polymer material.
BRPI0518855A2 (en) medicine for hygienic application to the ear
AR076139A1 (en) METHOD FOR TREATMENT OF CROPS WITH AN ENCAPSULATED PESTICIDE.
UY32503A (en) FORMULATION PESTICIDE FOR AGRICULTURAL USE BASED ON AVERMECTINE AND A PHOTOPROTECTOR AGENT
GT200400087A (en) AGENTS TO COMBAT PARASITES IN ANIMALS.
DK1749517T3 (en) Stable pharmaceutical composition of linezolid form IV
ATE392889T1 (en) ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
TW200635616A (en) Organic compounds
NI201200010A (en) PESTICIDE CARBOXAMIDES
EA200901148A1 (en) SUBCUTANE IMPLANTS, FREEDOMING ACTIVE COMPONENTS DURING THE LONG PERIOD OF TIME
CL2013000709A1 (en) Composition containing nifurtimox and an anthelmintic selected from: pf1022, emopdepside, tribendimidine, amidantel, bay d 9216, praziquantel or benzyl benzoate; useful in the treatment of diseases caused by giardias (div. sol. 1577-10).
ATE421330T1 (en) LIQUID ALLERGY VACCINE FORMULATION FOR OROMUCOSAL ADMINISTRATION
UA92604C2 (en) Stannsoporfin composition having a physiological osmolarity and use thereof
ATE451913T1 (en) SUBCUTANEOUS IMPLANTS THAT RELEASE AN ACTIVE SUBSTANCE OVER A LONGER PERIOD
AR059544A1 (en) COMBINATIONS OF ACTIVE PRINCIPLES WITH INSECTICIDES AND ACARICIDES
DE602005023881D1 (en) VETERINARY MEDICINE COMPOSITION WITH AN ARYLPYRAZOLE AND A NITROENAMINE WITH INCREASED ANTIPARASITIC ACTIVITY
EA200800733A1 (en) PHARMACEUTICAL CHITOSI FILLER FOR APPLICATION IN SOLID MEDICINE FORMS
DE602004022515D1 (en) FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2054037

Country of ref document: EP